ORCID ID: 0009-0008-6546-5745
Curriculum: Clinical Neuroscience
Tutor: Prof. Guido Cavaletti
Supervisor: Dr Maura Frigo
Workplace: School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore, 48, Monza, 20900, MB, Italy
I completed my degree in Medicine and Surgery cum Laude at the University of Milan on July 26, 2019, with the thesis “Innovative biomarkers for Prediction of disability progression in Multiple Sclerosis Patients” that I developed under the supervision of Professor Giuseppe Lauria Pinter during a 2-years internship period at IRCCS Carlo Besta, “Neuroimmunology and Neuromuscular Disease” Unit.
On January 31, 2025, I completed cum Laude the Residency Program in Neurology at University of Milano-Bicocca with the thesis “Use of fluid biomarkers for early prediction of disease progression in Multiple Sclerosis and to unravel pathophysiological mechanisms associated with Progression Independent of Relapse Activity” under the supervision of Professor Guido Cavaletti.
During my Residency and University years, I developed a particular interest in clinical Neuroimmunology and in the development of innovative fluid biomarkers of neuroinflammation, authoring some publications in scientific journals and presenting several contributions at national and international congresses.
Currently, I am pursuing a PhD in Clinical Neuroscience at the Department of Medicine and Surgery of the University of Milano-Bicocca and working as a Neurologist at the University Hospital IRCCS Fondazione San Gerardo Dei Tintori.
PhD research project
Fluid Biomarkers in Neurology
Abstract: Neurological diseases are among the leading causes of disability and death worldwide, and the central nervous system (CNS) is notoriously difficult to study directly due to its inaccessibility. Fluid biomarkers, which are molecules that can be measured with ultrasensitive detection methods in bodily fluids such as blood and cerebrospinal fluid, offer a potential solution. Reflecting biochemical processes occurring in the central nervous system (CNS), they provide insight into the presence, progression, and severity of neurological diseases.
The primary focus of my research project is to propose potential future directions for clinical application of innovative fluid biomarkers by i) investigating their potential use for early diagnosis, prognosis, and monitoring therapeutic intervention in neurological disorders, and (ii) by assessing the limitations linked to their use (including issues with specificity, sensitivity, and reproducibility).